Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- National Cancer Institute (NCI)
- Study ID
- NCT01087333
- Status
- Recruiting
Conditions
- Adult T Cell Lymphoma (ATL)
- Chronic Lymphocytic Leukemia (CLL)
- Cutaneous T Cell Lymphoma (CTCL)
- Hairy Cell Leukemia (HCL)
- Non-Hodgkins Lymphoma (NHL)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
Background: \- Researchers who are studying hairy cell leukemia, and how the disease compares with other disorders, are interested in obtaining additional samples from leukemia patients and healthy volunteers. The investigators are particularly interested in samples from individuals who have diseases that can be treated with a new type of drug called immunotoxin, in which an antibody carrying a toxin binds to a cancer cell and allows the toxin to kill the cell. Objectives: \- To collect a variety of clinical samples, including blood, urine, lymph samples, and other tissues, in order to study the samples and develop new treatments for leukemia. Eligibility: \- Individuals 18 years of age and older who have been diagnosed with leukemia or other kinds of blood and lymphatic system cancers, or who are healthy volunteers. Design: * Individuals who have leukemia will be asked to provide blood, bone marrow, urine, and tumor tissue samples as requested by the researchers. Healthy volunteers will provide only blood and urine samples. * No treatment will be given as part of this protocol.
Key Dates
- Start date
- Mar 2, 2010
- Status verified
- Oct 2025
Study Design
- Enrollment
- 1,263 participants (estimated)
Arms
- Arm: 1Patients with hematologic malignancies or solid tumors.
- Arm: 2Normal Donors who are defined as individuals without a diagnosis of or history of any cancer.
Primary Outcome Measure
Tissue Acquisition [ Time Frame: 4 weeks ]
Central Contacts
- Julie C Feurtado, R.N.(301) 480-6186
- Robert J Kreitman, M.D.(301) 648-7375
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | - |
Find similar trials in Bethesda, MD
Related Studies
- A Study of NX-2127 in Adults With Relapsed/Refractory B-cell MalignanciesPHASE1 · Recruiting · Nurix Therapeutics, Inc. · Duarte, California
- A Study of NX-5948 in Adults With Relapsed/Refractory B-cell MalignanciesPHASE1 · Recruiting · Nurix Therapeutics, Inc. · Duarte, California
- Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or VenetoclaxRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)PHASE2 · Recruiting · Nurix Therapeutics, Inc. · Duarte, California